Moderna, Inc. (MRNA) on Wednesday announced that it will bring drug product manufacturing to its existing Moderna Technology ...

The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.

The company reported $200 million in net losses for the third quarter, but an aggressive and highly successful cost-cutting ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

Moderna (MRNA) announced on Wednesday that it has completed its domestic end-to-end mRNA manufacturing network with the ...

Dec 2 (Reuters) - Moderna Inc's (MRNA.O), opens new tab COVID-19 vaccine could be approved for emergency use within 24 to 72 hours after the U.S. health regulator's advisory committee meeting, Chief ...

Moderna's CEO says that people will likely need a fourth dose of a COVID-19 vaccine later this year. According to The Washington Post and CNBC, Moderna CEO Stéphane Bancel said at a conference hosted ...

Moderna on Thursday said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine ...

Dec 4 (Reuters) - Moderna Inc (MRNA.O), opens new tab will be able to produce 500 million doses of its COVID-19 vaccine in 2021, Chief Executive Officer Stéphane Bancel said on Friday. The company has ...